The goal of the area of omics sciences known as metabolomics is to fully understand all of the metabolites that are present in a biological system. A key benefit of metabolomics is its ability to provide light on a variety of biological processes, including cellular metabolism, disease causes, and medication response, by examining the metabolome, which is essentially the chemical signature of cellular activity. Liquid chromatography-mass spectrometry (LC-MS) has become one of the most popular and commonly used analytical methods for metabolomics due to its adaptability and sensitivity.
What Does LC Test For?
LC is a separation method that is used to identify and analyze the components of a sample. It is often used to check the quantity and presence of different analytes, including tiny molecules, in intricate combinations. Pharmaceuticals, environmental analysis, food and beverage testing, clinical diagnostics, and metabolomics are just a few of the industries where LC may be used. Depending on the application, the particular analytes of interest in LC analysis might include, among other things, pharmaceuticals, metabolites, pesticides, environmental pollutants, and biomarkers.
Learn more about Liquid Chromatography-HPLC, UHPLC and LC-MS.
Diagram of the liquid chromatography system (Torre et al., 2015).
What is The Difference Between MS and LC-MS?
Molecules are ionized and separated from one another using the analytical method known as mass spectrometry (MS). It offers details on the examined substances' molecular weight, structure, and fragmentation pattern. The LC component of LC-MS separates the metabolites while the MS component identifies and quantifies them.
The sample introduction and separation processes are where MS and LC-MS diverge most. When compared to LC-MS, which enables the analysis of complicated mixtures, MS alone needs a pure sample. An suitable method for metabolomics investigation, LC-MS combines the resolving capability of LC with the detection and characterization skills of MS.
LC-MS in Metabolomics Analysis
Several LC-MS methods and instrument models are commonly employed in metabolomics research:
- Liquid chromatography-mass spectrometry (LC-MS/MS) combines tandem mass spectrometry with the strength of LC separation. It offers improved capacities for structural elucidation, sensitivity, and selectivity. Targeted metabolomics, which involves analyzing certain metabolites or groups of metabolites, frequently use LC-MS/MS.
- Ultra-High Performance Liquid Chromatography-Mass Spectrometry (UHPLC-MS): UHPLC-MS saves analytical time while boosting separation efficiency by utilizing high-pressure liquid chromatography systems with smaller column particle sizes. It enables high throughput testing of a large number of samples.
- Triple Quadrupole Mass Spectrometry (QQQ-MS): For focused metabolomics study, triple quadrupole mass spectrometers provide great sensitivity and selectivity. They are well-suited for quantitative metabolite profiling and stable isotope tracing investigations due to their superior quantification capabilities.
Commonly used LC-MS instrument models include the Thermo Fisher Scientific Q Exactive, Agilent 6495 Triple Quadrupole, and Waters Xevo TQ-S. These instruments offer high-resolution mass spectrometry and advanced data acquisition capabilities.
Workflow of LC-MS Analysis
Sample Preparation: Before analysis, biological samples such as blood, urine, or tissue extracts undergo various sample preparation steps. These steps include extraction, purification, and, in some cases, derivatization. The goal is to remove interfering substances, concentrate the target metabolites, and improve their ionization efficiency. Sample preparation greatly influences the quality and reproducibility of LC-MS results.
LC Separation: Liquid chromatography is employed to separate the metabolites based on their physicochemical properties. Reverse-phase chromatography is the most commonly used mode in metabolomics. It relies on differences in hydrophobicity to separate metabolites in a sample. Other chromatographic modes, such as normal-phase and ion exchange chromatography, can be employed depending on the specific requirements of the analysis. The choice of the appropriate LC method is critical for achieving optimal separation and peak resolution.
MS Detection: The separated metabolites are introduced into the mass spectrometer, where they are ionized, separated based on their mass-to-charge ratio (m/z), and detected. The ionization techniques commonly used in LC-MS analysis include electrospray ionization (ESI) and atmospheric pressure chemical ionization (APCI). ESI generates ions in the gas phase from the sample solution, while APCI involves ionization through chemical reactions with ions formed in the ion source. The choice of ionization technique depends on the analyte's properties and the instrument's capabilities.
Data Analysis: The acquired mass spectral data is processed using dedicated software tools. Peak detection, alignment, normalization, and statistical analysis are performed to identify significant features, determine relative metabolite concentrations, and discover potential biomarkers. Metabolite identification is accomplished by comparing the obtained mass spectra with reference databases or through the application of fragmentation pattern analysis and isotopic labeling experiments.
LC–MS-based serum metabolomic analysis (Mir et al., 2015)
Advanced LC-MS Applications in Metabolomics
1. Untargeted Metabolomics:
Untargeted metabolomics, which strives to completely profile all detected metabolites in a biological sample, makes extensive use of LC-MS. High-resolution mass spectrometry and advanced data analysis techniques are used in this strategy. Lipids, amino acids, organic acids, primary and secondary metabolites, as well as other metabolites, may all be detected using LC-MS. Untargeted metabolomics enables the identification of new metabolites, the discovery of metabolic pathways, and the detection of metabolic perturbations in many biological systems by studying the complex metabolite profiles. It offers a comprehensive perspective of the metabolome and can spot tiny alterations that can be a sign of illness or other biological processes.
Learn more about Untargeted Metabolomics Analysis Process.
2. Metabolic Flux Analysis:
LC-MS combined with stable isotope labeling techniques enables metabolic flux analysis, which involves studying the flow of metabolites through metabolic pathways. By introducing stable isotopes (such as 13C-labeled substrates) into the system, researchers can trace the incorporation of these isotopes into metabolites and measure their relative abundances using LC-MS. This information provides insights into metabolic pathway dynamics, flux distribution, and metabolic regulation. Metabolic flux analysis using LC-MS helps researchers understand the rate of metabolite production and consumption, identify key metabolic nodes, and investigate the response of metabolic pathways to different conditions or perturbations.
3. Pharmacometabolomics:
Pharmacometabolomics, which focuses on understanding the metabolic response to pharmacological therapy, relies heavily on LC-MS. Researchers can comprehend drug metabolism, find novel therapeutic targets, forecast medication effectiveness, and decipher the mechanisms underlying drug toxicity by examining changes in the metabolome following drug delivery. Drug-related metabolites and metabolic pathways can be recognized and measured using LC-MS. It may identify parent medications as well as their metabolites, giving important details on drug metabolism, bioactivation, and excretion. Pharmacometabolomics using LC-MS can support personalized medicine strategies by locating drug response biomarkers, optimizing medication dosage, and enhancing therapeutic effects.
4. Microbiota Metabolomics:
The investigation of the metabolites produced by the gut microbiota has drawn a lot of interest recently. In order to understand host-microbe interactions, discover microbial markers, and investigate the function of the microbiota in health and illness, LC-MS is used to examine the metabolic products of the gut microbiome. Numerous microbial metabolites, including short-chain fatty acids, secondary metabolites, bile acids, and other bioactive substances, may be identified and quantified using LC-MS. Researchers may learn how the gut microbiota affects host metabolism, modifies immunological function, and plays a role in the development of several illnesses, such as obesity, inflammatory bowel disease, and metabolic disorders, by analyzing the metabolic profiles of the gut microbiota using LC-MS.
5. Metabolite Imaging:
LC-MS imaging combines the separation power of liquid chromatography with mass spectrometry imaging techniques, enabling the spatial visualization of metabolites within tissues or cells. This approach allows researchers to create detailed maps of metabolite distributions within biological samples. LC-MS imaging can provide valuable information on metabolite localization, metabolic heterogeneity within tissues, and the spatial organization of metabolic pathways. It enables the identification and spatial characterization of metabolites associated with specific cellular compartments, disease lesions, or biological processes. LC-MS imaging has applications in understanding tissue-specific metabolism, drug distribution within tissues, and disease pathology.
6. Multi-Omics Integration:
To facilitate the integration of multi-omics data, LC-MS is frequently combined with other omics technologies as genomics, transcriptomics, and proteomics. Researchers may find intricate relationships between genes, proteins, and metabolites and develop a comprehensive knowledge of biological systems by merging several layers of molecular data. By giving metabolite-level information that supplements other omics data, LC-MS makes a contribution to multi-omics investigations. Incorporating LC-MS data with genomes, transcriptomics, and proteomics data enables researchers to build complete metabolic networks, perform systems-level studies, and analyze the connections between various molecular levels. Our understanding of biological processes, disease causes, and medication responses is improved by this integrated approach.
References
- Torre, César Aquiles Lázaro de la, et al. "Chromatographic detection of nitrofurans in foods of animal origin." Arquivos do Instituto Biológico 82 (2015): 1-9.
- Mir, Sartaj Ahmad, et al. "LC–MS-based serum metabolomic analysis reveals dysregulation of phosphatidylcholines in esophageal squamous cell carcinoma." Journal of proteomics 127 (2015): 96-102.
For Research Use Only. Not for use in diagnostic procedures.